AU2008218195C1 - Compositions and methods for altering gene expression - Google Patents
Compositions and methods for altering gene expression Download PDFInfo
- Publication number
- AU2008218195C1 AU2008218195C1 AU2008218195A AU2008218195A AU2008218195C1 AU 2008218195 C1 AU2008218195 C1 AU 2008218195C1 AU 2008218195 A AU2008218195 A AU 2008218195A AU 2008218195 A AU2008218195 A AU 2008218195A AU 2008218195 C1 AU2008218195 C1 AU 2008218195C1
- Authority
- AU
- Australia
- Prior art keywords
- cfa
- cfaaffx
- composition
- animal
- ppm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 156
- 230000014509 gene expression Effects 0.000 title claims abstract description 53
- 238000000034 method Methods 0.000 title claims abstract description 44
- 241001465754 Metazoa Species 0.000 claims abstract description 70
- 230000001105 regulatory effect Effects 0.000 claims abstract description 22
- 108090000623 proteins and genes Proteins 0.000 claims description 77
- 235000013305 food Nutrition 0.000 claims description 24
- 241000282465 Canis Species 0.000 claims description 17
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 14
- 235000015097 nutrients Nutrition 0.000 claims description 14
- 201000010099 disease Diseases 0.000 claims description 13
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 12
- 230000035935 pregnancy Effects 0.000 claims description 11
- 235000018102 proteins Nutrition 0.000 claims description 11
- 102000004169 proteins and genes Human genes 0.000 claims description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 10
- 230000009286 beneficial effect Effects 0.000 claims description 10
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 9
- 239000004472 Lysine Substances 0.000 claims description 9
- 230000004048 modification Effects 0.000 claims description 9
- 238000012986 modification Methods 0.000 claims description 9
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 8
- 229930003427 Vitamin E Natural products 0.000 claims description 8
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 8
- 229930182817 methionine Natural products 0.000 claims description 8
- 210000004291 uterus Anatomy 0.000 claims description 8
- 235000019165 vitamin E Nutrition 0.000 claims description 8
- 229940046009 vitamin E Drugs 0.000 claims description 8
- 239000011709 vitamin E Substances 0.000 claims description 8
- 229960004203 carnitine Drugs 0.000 claims description 7
- 230000037361 pathway Effects 0.000 claims description 7
- 229940088594 vitamin Drugs 0.000 claims description 7
- 229930003231 vitamin Natural products 0.000 claims description 7
- 235000013343 vitamin Nutrition 0.000 claims description 7
- 239000011782 vitamin Substances 0.000 claims description 7
- 229960001231 choline Drugs 0.000 claims description 6
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 6
- 235000019197 fats Nutrition 0.000 claims description 6
- 229960003080 taurine Drugs 0.000 claims description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 5
- 229930003268 Vitamin C Natural products 0.000 claims description 5
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 5
- 235000019154 vitamin C Nutrition 0.000 claims description 5
- 239000011718 vitamin C Substances 0.000 claims description 5
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims description 4
- 150000001720 carbohydrates Chemical class 0.000 claims description 4
- 235000014633 carbohydrates Nutrition 0.000 claims description 4
- 239000011707 mineral Substances 0.000 claims description 4
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 4
- 235000013325 dietary fiber Nutrition 0.000 claims description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 3
- 235000010755 mineral Nutrition 0.000 claims description 3
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 2
- 239000011572 manganese Substances 0.000 claims description 2
- 229910052748 manganese Inorganic materials 0.000 claims description 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 claims 2
- 238000011161 development Methods 0.000 description 13
- 230000018109 developmental process Effects 0.000 description 13
- 230000001413 cellular effect Effects 0.000 description 11
- 241000282472 Canis lupus familiaris Species 0.000 description 8
- 229940024606 amino acid Drugs 0.000 description 8
- 150000001413 amino acids Chemical class 0.000 description 8
- 235000020776 essential amino acid Nutrition 0.000 description 8
- 238000009472 formulation Methods 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- LOGFVTREOLYCPF-KXNHARMFSA-N (2s,3r)-2-[[(2r)-1-[(2s)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoic acid Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H]1CCCN1C(=O)[C@@H](N)CCCCN LOGFVTREOLYCPF-KXNHARMFSA-N 0.000 description 7
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 7
- 108010067306 Fibronectins Proteins 0.000 description 7
- 102000016359 Fibronectins Human genes 0.000 description 7
- 108090000193 Interleukin-1 beta Proteins 0.000 description 7
- 102000003777 Interleukin-1 beta Human genes 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 7
- 108010091383 Xanthine dehydrogenase Proteins 0.000 description 7
- 102000005773 Xanthine dehydrogenase Human genes 0.000 description 7
- 108010093894 Xanthine oxidase Proteins 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 7
- 201000011510 cancer Diseases 0.000 description 7
- 210000000349 chromosome Anatomy 0.000 description 7
- 239000003797 essential amino acid Substances 0.000 description 7
- 102100037362 Fibronectin Human genes 0.000 description 6
- 101001027128 Homo sapiens Fibronectin Proteins 0.000 description 6
- 210000000988 bone and bone Anatomy 0.000 description 6
- 230000003828 downregulation Effects 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 108010060385 Cyclin B1 Proteins 0.000 description 5
- 108010038537 Dual Specificity Phosphatase 1 Proteins 0.000 description 5
- 102100034428 Dual specificity protein phosphatase 1 Human genes 0.000 description 5
- 241000282326 Felis catus Species 0.000 description 5
- 102100032340 G2/mitotic-specific cyclin-B1 Human genes 0.000 description 5
- 102100033272 Macrophage receptor MARCO Human genes 0.000 description 5
- 101710089357 Macrophage receptor MARCO Proteins 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 5
- 235000020774 essential nutrients Nutrition 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- 238000002493 microarray Methods 0.000 description 5
- 230000022983 regulation of cell cycle Effects 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 230000003827 upregulation Effects 0.000 description 5
- 101000916644 Homo sapiens Macrophage colony-stimulating factor 1 receptor Proteins 0.000 description 4
- 101000861454 Homo sapiens Protein c-Fos Proteins 0.000 description 4
- 102100028198 Macrophage colony-stimulating factor 1 receptor Human genes 0.000 description 4
- 208000021642 Muscular disease Diseases 0.000 description 4
- 102400000058 Neuregulin-1 Human genes 0.000 description 4
- 108090000556 Neuregulin-1 Proteins 0.000 description 4
- 102100027584 Protein c-Fos Human genes 0.000 description 4
- 102000007537 Type II DNA Topoisomerases Human genes 0.000 description 4
- 108010046308 Type II DNA Topoisomerases Proteins 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 206010003246 arthritis Diseases 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000022131 cell cycle Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 102100022749 Aminopeptidase N Human genes 0.000 description 3
- 102100032952 Condensin complex subunit 3 Human genes 0.000 description 3
- 101710100311 Condensin-2 complex subunit G2 Proteins 0.000 description 3
- 102100032980 Condensin-2 complex subunit G2 Human genes 0.000 description 3
- 108010060387 Cyclin B2 Proteins 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 102100033201 G2/mitotic-specific cyclin-B2 Human genes 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 101000942622 Homo sapiens Condensin complex subunit 3 Proteins 0.000 description 3
- 101001112162 Homo sapiens Kinetochore protein NDC80 homolog Proteins 0.000 description 3
- 101000590482 Homo sapiens Kinetochore protein Nuf2 Proteins 0.000 description 3
- 101000971404 Homo sapiens Protein kinase C iota type Proteins 0.000 description 3
- 101000980827 Homo sapiens T-cell surface glycoprotein CD1a Proteins 0.000 description 3
- 102100023890 Kinetochore protein NDC80 homolog Human genes 0.000 description 3
- 102100032431 Kinetochore protein Nuf2 Human genes 0.000 description 3
- 102100022646 Normal mucosa of esophagus-specific gene 1 protein Human genes 0.000 description 3
- 101710167562 Normal mucosa of esophagus-specific gene 1 protein Proteins 0.000 description 3
- 102100021557 Protein kinase C iota type Human genes 0.000 description 3
- 102100024219 T-cell surface glycoprotein CD1a Human genes 0.000 description 3
- 102000008228 Toll-like receptor 2 Human genes 0.000 description 3
- 108010060888 Toll-like receptor 2 Proteins 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 150000001556 benzimidazoles Chemical class 0.000 description 3
- 230000037180 bone health Effects 0.000 description 3
- 230000008209 cardiovascular development Effects 0.000 description 3
- 230000034303 cell budding Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 210000003917 human chromosome Anatomy 0.000 description 3
- 230000005934 immune activation Effects 0.000 description 3
- 210000001503 joint Anatomy 0.000 description 3
- 230000037231 joint health Effects 0.000 description 3
- 230000037356 lipid metabolism Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000004118 muscle contraction Effects 0.000 description 3
- 235000006180 nutrition needs Nutrition 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 101150028074 2 gene Proteins 0.000 description 2
- 102100033735 Bactericidal permeability-increasing protein Human genes 0.000 description 2
- 102100028253 Breast cancer anti-estrogen resistance protein 3 Human genes 0.000 description 2
- 101710119240 Breast cancer anti-estrogen resistance protein 3 Proteins 0.000 description 2
- 108010049990 CD13 Antigens Proteins 0.000 description 2
- 102000004178 Cathepsin E Human genes 0.000 description 2
- 108090000611 Cathepsin E Proteins 0.000 description 2
- 108010009685 Cholinergic Receptors Proteins 0.000 description 2
- 102100033682 Cilia- and flagella-associated protein 69 Human genes 0.000 description 2
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 2
- 102000003706 Complement factor D Human genes 0.000 description 2
- 108090000059 Complement factor D Proteins 0.000 description 2
- 230000004543 DNA replication Effects 0.000 description 2
- 101001008952 Dictyostelium discoideum Kinesin-related protein 11 Proteins 0.000 description 2
- 102100025682 Dystroglycan 1 Human genes 0.000 description 2
- 108010071885 Dystroglycans Proteins 0.000 description 2
- 102100036281 E3 ubiquitin-protein ligase RNF152 Human genes 0.000 description 2
- 101710162502 E3 ubiquitin-protein ligase RNF152 Proteins 0.000 description 2
- 241000282324 Felis Species 0.000 description 2
- 102100038647 Fibroleukin Human genes 0.000 description 2
- 102100031547 HLA class II histocompatibility antigen, DO alpha chain Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 101000871785 Homo sapiens Bactericidal permeability-increasing protein Proteins 0.000 description 2
- 101000944490 Homo sapiens Cilia- and flagella-associated protein 69 Proteins 0.000 description 2
- 101001031613 Homo sapiens Fibroleukin Proteins 0.000 description 2
- 101000866278 Homo sapiens HLA class II histocompatibility antigen, DO alpha chain Proteins 0.000 description 2
- 101000913079 Homo sapiens IgG receptor FcRn large subunit p51 Proteins 0.000 description 2
- 101001008953 Homo sapiens Kinesin-like protein KIF11 Proteins 0.000 description 2
- 101000605743 Homo sapiens Kinesin-like protein KIF23 Proteins 0.000 description 2
- 101001053809 Homo sapiens Kinetochore-associated protein DSN1 homolog Proteins 0.000 description 2
- 101001039359 Homo sapiens Probable G-protein coupled receptor 158 Proteins 0.000 description 2
- 101000684673 Homo sapiens Protein APCDD1 Proteins 0.000 description 2
- 102100026120 IgG receptor FcRn large subunit p51 Human genes 0.000 description 2
- 102100026216 Immunoglobulin heavy constant alpha 2 Human genes 0.000 description 2
- 101710144859 Immunoglobulin heavy constant alpha 2 Proteins 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 102100027629 Kinesin-like protein KIF11 Human genes 0.000 description 2
- 102100038406 Kinesin-like protein KIF23 Human genes 0.000 description 2
- 102100024062 Kinetochore-associated protein DSN1 homolog Human genes 0.000 description 2
- 102100023738 Lysophosphatidylcholine acyltransferase 2 Human genes 0.000 description 2
- 101710143643 Lysophosphatidylcholine acyltransferase 2 Proteins 0.000 description 2
- 102100036203 Microfibrillar-associated protein 5 Human genes 0.000 description 2
- 101710147471 Microfibrillar-associated protein 5 Proteins 0.000 description 2
- 102100022165 Nuclear factor 1 B-type Human genes 0.000 description 2
- 101710170464 Nuclear factor 1 B-type Proteins 0.000 description 2
- 229940122344 Peptidase inhibitor Drugs 0.000 description 2
- 102100041031 Probable G-protein coupled receptor 158 Human genes 0.000 description 2
- 102100023735 Protein APCDD1 Human genes 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 102000000395 SH3 domains Human genes 0.000 description 2
- 108050008861 SH3 domains Proteins 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 108050000761 Serpin Proteins 0.000 description 2
- 102000008847 Serpin Human genes 0.000 description 2
- 102100028503 Transcription factor EC Human genes 0.000 description 2
- 101710162523 Transcription factor EC Proteins 0.000 description 2
- 102000004243 Tubulin Human genes 0.000 description 2
- 108090000704 Tubulin Proteins 0.000 description 2
- 102000014384 Type C Phospholipases Human genes 0.000 description 2
- 108010079194 Type C Phospholipases Proteins 0.000 description 2
- 102100028437 Versican core protein Human genes 0.000 description 2
- 101710200894 Versican core protein Proteins 0.000 description 2
- -1 about 3000 Chemical compound 0.000 description 2
- 102000034337 acetylcholine receptors Human genes 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 230000005779 cell damage Effects 0.000 description 2
- 108010031377 centromere protein F Proteins 0.000 description 2
- 235000017471 coenzyme Q10 Nutrition 0.000 description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000003551 muscarinic effect Effects 0.000 description 2
- 230000004220 muscle function Effects 0.000 description 2
- 230000007472 neurodevelopment Effects 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 210000002307 prostate Anatomy 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 235000011649 selenium Nutrition 0.000 description 2
- 239000003001 serine protease inhibitor Substances 0.000 description 2
- GJJVAFUKOBZPCB-ZGRPYONQSA-N (r)-3,4-dihydro-2-methyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2h-1-benzopyran-6-ol Chemical class OC1=CC=C2OC(CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-ZGRPYONQSA-N 0.000 description 1
- 102100034493 28S ribosomal protein S17, mitochondrial Human genes 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 102100030089 ATP-dependent RNA helicase DHX8 Human genes 0.000 description 1
- 102100022117 Abnormal spindle-like microcephaly-associated protein Human genes 0.000 description 1
- 101710187032 Abnormal spindle-like microcephaly-associated protein Proteins 0.000 description 1
- 102100030381 Acetyl-coenzyme A synthetase 2-like, mitochondrial Human genes 0.000 description 1
- 101710179225 Acetyl-coenzyme A synthetase 2-like, mitochondrial Proteins 0.000 description 1
- 102100034542 Acyl-CoA (8-3)-desaturase Human genes 0.000 description 1
- 101710102367 Acyl-CoA (8-3)-desaturase Proteins 0.000 description 1
- 101710159293 Acyl-CoA desaturase 1 Proteins 0.000 description 1
- 102100026439 Adhesion G protein-coupled receptor E1 Human genes 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102100034280 Ankyrin repeat domain-containing protein 26 Human genes 0.000 description 1
- 108010049777 Ankyrins Proteins 0.000 description 1
- 102000008102 Ankyrins Human genes 0.000 description 1
- 102100034278 Annexin A6 Human genes 0.000 description 1
- 108090000656 Annexin A6 Proteins 0.000 description 1
- 108050006915 Aquaporin 7 Proteins 0.000 description 1
- 102100029406 Aquaporin-7 Human genes 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 102000008154 Bone Morphogenetic Protein 6 Human genes 0.000 description 1
- 108010049974 Bone Morphogenetic Protein 6 Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 102100031696 CCR4-NOT transcription complex subunit 10 Human genes 0.000 description 1
- 108010009992 CD163 antigen Proteins 0.000 description 1
- 108700020472 CDC20 Proteins 0.000 description 1
- 101100135641 Caenorhabditis elegans par-3 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 108010045403 Calcium-Binding Proteins Proteins 0.000 description 1
- 102000005701 Calcium-Binding Proteins Human genes 0.000 description 1
- 102100035768 Calcyphosin-like protein Human genes 0.000 description 1
- 102400001321 Cathepsin L Human genes 0.000 description 1
- 108090000624 Cathepsin L Proteins 0.000 description 1
- 102100032141 Cell death activator CIDE-A Human genes 0.000 description 1
- 101710196996 Cell death activator CIDE-A Proteins 0.000 description 1
- 102100023344 Centromere protein F Human genes 0.000 description 1
- 102100033129 Centrosomal protein of 112 kDa Human genes 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 102100040484 Claspin Human genes 0.000 description 1
- 101710117926 Claspin Proteins 0.000 description 1
- 102100035436 Complement factor D Human genes 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000709687 Coxsackievirus Species 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 102000009902 Cytochrome P-450 CYP1B1 Human genes 0.000 description 1
- 108010077090 Cytochrome P-450 CYP1B1 Proteins 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- 102100025405 DENN domain-containing protein 5B Human genes 0.000 description 1
- 102100037753 DEP domain-containing protein 1A Human genes 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 230000028937 DNA protection Effects 0.000 description 1
- 102100034289 Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 Human genes 0.000 description 1
- 101710103779 Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 Proteins 0.000 description 1
- 102100034430 Dual specificity protein phosphatase 19 Human genes 0.000 description 1
- 102100031539 E3 ubiquitin-protein ligase RNF144B Human genes 0.000 description 1
- 102100029065 EF-hand domain-containing family member C2 Human genes 0.000 description 1
- 102100029650 EH domain-binding protein 1-like protein 1 Human genes 0.000 description 1
- 101710043325 EMILIN-2 Proteins 0.000 description 1
- 102100032064 EMILIN-2 Human genes 0.000 description 1
- 102100035183 ERC protein 2 Human genes 0.000 description 1
- 102000008013 Electron Transport Complex I Human genes 0.000 description 1
- 108010089760 Electron Transport Complex I Proteins 0.000 description 1
- 102100023733 Ephrin-B3 Human genes 0.000 description 1
- 108010044085 Ephrin-B3 Proteins 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 208000005917 Exostoses Diseases 0.000 description 1
- 102100021654 Extracellular sulfatase Sulf-2 Human genes 0.000 description 1
- 102100022116 F-box only protein 2 Human genes 0.000 description 1
- 101710199775 F-box only protein 2 Proteins 0.000 description 1
- 102100030771 Ferrochelatase, mitochondrial Human genes 0.000 description 1
- 102100026121 Flap endonuclease 1 Human genes 0.000 description 1
- 108050002219 Flap endonuclease 1 Proteins 0.000 description 1
- 108091006027 G proteins Proteins 0.000 description 1
- 102000030782 GTP binding Human genes 0.000 description 1
- 108091000058 GTP-Binding Proteins 0.000 description 1
- 101710180281 Glutamate-tRNA ligase 2 Proteins 0.000 description 1
- 101710170366 GlutamylGlutaminyl-tRNA synthetase Proteins 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000001989 Glypican-6 Human genes 0.000 description 1
- 108050009385 Glypican-6 Proteins 0.000 description 1
- 102100027685 Hemoglobin subunit alpha Human genes 0.000 description 1
- 102100030826 Hemoglobin subunit epsilon Human genes 0.000 description 1
- 101000639837 Homo sapiens 28S ribosomal protein S17, mitochondrial Proteins 0.000 description 1
- 101000774738 Homo sapiens A-kinase anchor protein 2 Proteins 0.000 description 1
- 101000864666 Homo sapiens ATP-dependent RNA helicase DHX8 Proteins 0.000 description 1
- 101000718225 Homo sapiens Adhesion G protein-coupled receptor E1 Proteins 0.000 description 1
- 101000757160 Homo sapiens Aminopeptidase N Proteins 0.000 description 1
- 101000780116 Homo sapiens Ankyrin repeat domain-containing protein 26 Proteins 0.000 description 1
- 101000993437 Homo sapiens CCR4-NOT transcription complex subunit 10 Proteins 0.000 description 1
- 101000715551 Homo sapiens Calcyphosin-like protein Proteins 0.000 description 1
- 101000944325 Homo sapiens Centrosomal protein of 112 kDa Proteins 0.000 description 1
- 101000737554 Homo sapiens Complement factor D Proteins 0.000 description 1
- 101000722005 Homo sapiens DENN domain-containing protein 5B Proteins 0.000 description 1
- 101000950642 Homo sapiens DEP domain-containing protein 1A Proteins 0.000 description 1
- 101000924027 Homo sapiens Dual specificity protein phosphatase 19 Proteins 0.000 description 1
- 101001130266 Homo sapiens E3 ubiquitin-protein ligase RNF144B Proteins 0.000 description 1
- 101000840931 Homo sapiens EF-hand domain-containing family member C2 Proteins 0.000 description 1
- 101001012961 Homo sapiens EH domain-binding protein 1-like protein 1 Proteins 0.000 description 1
- 101000876444 Homo sapiens ERC protein 2 Proteins 0.000 description 1
- 101000820626 Homo sapiens Extracellular sulfatase Sulf-2 Proteins 0.000 description 1
- 101000843611 Homo sapiens Ferrochelatase, mitochondrial Proteins 0.000 description 1
- 101001009007 Homo sapiens Hemoglobin subunit alpha Proteins 0.000 description 1
- 101001083591 Homo sapiens Hemoglobin subunit epsilon Proteins 0.000 description 1
- 101001031977 Homo sapiens Hemoglobin subunit gamma-1 Proteins 0.000 description 1
- 101001044094 Homo sapiens Inositol monophosphatase 2 Proteins 0.000 description 1
- 101000971521 Homo sapiens Kinetochore scaffold 1 Proteins 0.000 description 1
- 101001138022 Homo sapiens La-related protein 1 Proteins 0.000 description 1
- 101000745469 Homo sapiens Lambda-crystallin homolog Proteins 0.000 description 1
- 101000941879 Homo sapiens Leucine-rich repeat serine/threonine-protein kinase 2 Proteins 0.000 description 1
- 101001137975 Homo sapiens Leucyl-cystinyl aminopeptidase Proteins 0.000 description 1
- 101000605076 Homo sapiens Ligand-dependent nuclear receptor corepressor-like protein Proteins 0.000 description 1
- 101001018100 Homo sapiens Lysozyme C Proteins 0.000 description 1
- 101000634835 Homo sapiens M1-specific T cell receptor alpha chain Proteins 0.000 description 1
- 101001011499 Homo sapiens MAPK-interacting and spindle-stabilizing protein-like Proteins 0.000 description 1
- 101000581402 Homo sapiens Melanin-concentrating hormone receptor 1 Proteins 0.000 description 1
- 101000957259 Homo sapiens Mitotic spindle assembly checkpoint protein MAD2A Proteins 0.000 description 1
- 101000634545 Homo sapiens Neuronal PAS domain-containing protein 3 Proteins 0.000 description 1
- 101001120794 Homo sapiens Opioid growth factor receptor-like protein 1 Proteins 0.000 description 1
- 101000585555 Homo sapiens PCNA-associated factor Proteins 0.000 description 1
- 101000693243 Homo sapiens Paternally-expressed gene 3 protein Proteins 0.000 description 1
- 101001001852 Homo sapiens Phospholipase B-like 1 Proteins 0.000 description 1
- 101001070479 Homo sapiens Probable G-protein coupled receptor 101 Proteins 0.000 description 1
- 101001068628 Homo sapiens Protein PRRC2C Proteins 0.000 description 1
- 101000703132 Homo sapiens Regulator of G-protein signaling 7 Proteins 0.000 description 1
- 101000575639 Homo sapiens Ribonucleoside-diphosphate reductase subunit M2 Proteins 0.000 description 1
- 101000588012 Homo sapiens SREBP regulating gene protein Proteins 0.000 description 1
- 101000661821 Homo sapiens Serine/threonine-protein kinase 17A Proteins 0.000 description 1
- 101000600885 Homo sapiens Serine/threonine-protein kinase NIM1 Proteins 0.000 description 1
- 101000654500 Homo sapiens Signal-induced proliferation-associated 1-like protein 2 Proteins 0.000 description 1
- 101001010113 Homo sapiens Solute carrier family 2, facilitated glucose transporter member 9 Proteins 0.000 description 1
- 101000633677 Homo sapiens Spindle and kinetochore-associated protein 3 Proteins 0.000 description 1
- 101000634836 Homo sapiens T cell receptor alpha chain MC.7.G5 Proteins 0.000 description 1
- 101000773122 Homo sapiens Thioredoxin domain-containing protein 5 Proteins 0.000 description 1
- 101000835726 Homo sapiens Transcription elongation factor A protein 3 Proteins 0.000 description 1
- 101000955409 Homo sapiens Xyloside xylosyltransferase 1 Proteins 0.000 description 1
- 102000030513 Homogentisate 1,2-Dioxygenase Human genes 0.000 description 1
- 108700023439 Homogentisate 1,2-dioxygenases Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102100029610 Immunoglobulin lambda constant 1 Human genes 0.000 description 1
- 101710154856 Immunoglobulin lambda constant 1 Proteins 0.000 description 1
- 102100020985 Immunoglobulin mu heavy chain Human genes 0.000 description 1
- 101710099741 Immunoglobulin mu heavy chain Proteins 0.000 description 1
- 102100021608 Inositol monophosphatase 2 Human genes 0.000 description 1
- 102000015564 Islet cell autoantigen 1 Human genes 0.000 description 1
- 108050004848 Islet cell autoantigen 1 Proteins 0.000 description 1
- 102100021464 Kinetochore scaffold 1 Human genes 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 102100020859 La-related protein 1 Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 102100032241 Lactotransferrin Human genes 0.000 description 1
- 102100039324 Lambda-crystallin homolog Human genes 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 102100032693 Leucine-rich repeat serine/threonine-protein kinase 2 Human genes 0.000 description 1
- 102100020872 Leucyl-cystinyl aminopeptidase Human genes 0.000 description 1
- 102100038259 Ligand-dependent nuclear receptor corepressor-like protein Human genes 0.000 description 1
- 102100033468 Lysozyme C Human genes 0.000 description 1
- 102100029450 M1-specific T cell receptor alpha chain Human genes 0.000 description 1
- 102100030165 MAPK-interacting and spindle-stabilizing protein-like Human genes 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102100030612 Mast cell carboxypeptidase A Human genes 0.000 description 1
- 101710119290 Mast cell carboxypeptidase A Proteins 0.000 description 1
- 102100027375 Melanin-concentrating hormone receptor 1 Human genes 0.000 description 1
- 102100038792 Mitotic spindle assembly checkpoint protein MAD2A Human genes 0.000 description 1
- 102100023354 Multimerin-1 Human genes 0.000 description 1
- 101710130567 Multimerin-1 Proteins 0.000 description 1
- 108060008487 Myosin Proteins 0.000 description 1
- 102000003505 Myosin Human genes 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 102000051584 NAD kinases Human genes 0.000 description 1
- 108010084634 NADP phosphatase Proteins 0.000 description 1
- 102100029051 Neuronal PAS domain-containing protein 3 Human genes 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 102100026074 Opioid growth factor receptor-like protein 1 Human genes 0.000 description 1
- 102000016304 Origin Recognition Complex Human genes 0.000 description 1
- 108010067244 Origin Recognition Complex Proteins 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 102100037601 P2X purinoceptor 4 Human genes 0.000 description 1
- 102100029879 PCNA-associated factor Human genes 0.000 description 1
- 102100037134 Partitioning defective 3 homolog B Human genes 0.000 description 1
- 101710183220 Partitioning defective 3 homolog B Proteins 0.000 description 1
- 102100025757 Paternally-expressed gene 3 protein Human genes 0.000 description 1
- 102100036316 Phospholipase B-like 1 Human genes 0.000 description 1
- 102000007074 Phospholipase C beta Human genes 0.000 description 1
- 108010047834 Phospholipase C beta Proteins 0.000 description 1
- 101710171421 Phosphoprotein 32 Proteins 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 102100034137 Probable G-protein coupled receptor 101 Human genes 0.000 description 1
- 108010049395 Prokaryotic Initiation Factor-2 Proteins 0.000 description 1
- 102100033952 Protein PRRC2C Human genes 0.000 description 1
- 108010080192 Purinergic Receptors Proteins 0.000 description 1
- 102100030715 Regulator of G-protein signaling 7 Human genes 0.000 description 1
- 102000041282 Rh family Human genes 0.000 description 1
- 108091061346 Rh family Proteins 0.000 description 1
- 102100031354 Rho GTPase-activating protein 11A Human genes 0.000 description 1
- 101710129852 Rho GTPase-activating protein 11A Proteins 0.000 description 1
- 102100026006 Ribonucleoside-diphosphate reductase subunit M2 Human genes 0.000 description 1
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 1
- 102100029989 SHC SH2 domain-binding protein 1 Human genes 0.000 description 1
- 101710140556 SHC SH2 domain-binding protein 1 Proteins 0.000 description 1
- 102000037054 SLC-Transporter Human genes 0.000 description 1
- 108091006207 SLC-Transporter Proteins 0.000 description 1
- 102100031580 SREBP regulating gene protein Human genes 0.000 description 1
- 102100025831 Scavenger receptor cysteine-rich type 1 protein M130 Human genes 0.000 description 1
- 102100037955 Serine/threonine-protein kinase 17A Human genes 0.000 description 1
- 102100037345 Serine/threonine-protein kinase NIM1 Human genes 0.000 description 1
- 102100030267 Serine/threonine-protein kinase PLK4 Human genes 0.000 description 1
- 101710183229 Serine/threonine-protein kinase PLK4 Proteins 0.000 description 1
- 102100031451 Signal-induced proliferation-associated 1-like protein 2 Human genes 0.000 description 1
- 102100030935 Solute carrier family 2, facilitated glucose transporter member 9 Human genes 0.000 description 1
- 102100038626 Sorting nexin-6 Human genes 0.000 description 1
- 108050006109 Sorting nexin-6 Proteins 0.000 description 1
- 102100029220 Spindle and kinetochore-associated protein 3 Human genes 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 102100021681 Syntaxin-binding protein 6 Human genes 0.000 description 1
- 101710096101 Syntaxin-binding protein 6 Proteins 0.000 description 1
- 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 description 1
- 102100030269 Thioredoxin domain-containing protein 5 Human genes 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 108010023603 Transcobalamins Proteins 0.000 description 1
- 102000011409 Transcobalamins Human genes 0.000 description 1
- 102100026427 Transcription elongation factor A protein 3 Human genes 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 102100033726 Tumor necrosis factor receptor superfamily member 17 Human genes 0.000 description 1
- 101710187885 Tumor necrosis factor receptor superfamily member 17 Proteins 0.000 description 1
- 108010005656 Ubiquitin Thiolesterase Proteins 0.000 description 1
- 102100037587 Ubiquitin carboxyl-terminal hydrolase BAP1 Human genes 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 108010036639 WW Domain-Containing Oxidoreductase Proteins 0.000 description 1
- 102100027534 WW domain-containing oxidoreductase Human genes 0.000 description 1
- 102100039027 Xyloside xylosyltransferase 1 Human genes 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229960001570 ademetionine Drugs 0.000 description 1
- 108010084938 adenovirus receptor Proteins 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 102000052586 bactericidal permeability increasing protein Human genes 0.000 description 1
- 108010032816 bactericidal permeability increasing protein Proteins 0.000 description 1
- 235000004251 balanced diet Nutrition 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000008236 biological pathway Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 230000036996 cardiovascular health Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 239000002771 cell marker Substances 0.000 description 1
- 102000005352 centromere protein F Human genes 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 150000001944 cysteine derivatives Chemical class 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 208000037765 diseases and disorders Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000001819 effect on gene Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 235000021321 essential mineral Nutrition 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 125000004387 flavanoid group Chemical group 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000001965 increasing effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 229960001518 levocarnitine Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000021048 nutrient requirements Nutrition 0.000 description 1
- 230000001234 nutrigenomic effect Effects 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 238000002559 palpation Methods 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 150000003906 phosphoinositides Chemical class 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229940091258 selenium supplement Drugs 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000003687 soy isoflavones Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 229930003802 tocotrienol Natural products 0.000 description 1
- 239000011731 tocotrienol Substances 0.000 description 1
- 229940068778 tocotrienols Drugs 0.000 description 1
- 235000019148 tocotrienols Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 108010069411 transcription factor S-II Proteins 0.000 description 1
- 230000014621 translational initiation Effects 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/30—Oligoelements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Birds (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89117107P | 2007-02-22 | 2007-02-22 | |
| US60/891,171 | 2007-02-22 | ||
| PCT/US2008/054800 WO2008103958A1 (en) | 2007-02-22 | 2008-02-22 | Compositions and methods for altering gene expression |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| AU2008218195A1 AU2008218195A1 (en) | 2008-08-28 |
| AU2008218195B2 AU2008218195B2 (en) | 2011-11-03 |
| AU2008218195C1 true AU2008218195C1 (en) | 2012-05-24 |
Family
ID=39563552
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2008218176A Ceased AU2008218176B2 (en) | 2007-02-22 | 2008-02-22 | Compositions and methods for enhancing the development of growing animals |
| AU2008218187A Ceased AU2008218187C1 (en) | 2007-02-22 | 2008-02-22 | Compositions and methods for enhancing immune system of felines |
| AU2008218195A Ceased AU2008218195C1 (en) | 2007-02-22 | 2008-02-22 | Compositions and methods for altering gene expression |
| AU2008218193A Ceased AU2008218193B2 (en) | 2007-02-22 | 2008-02-22 | Compositions and methods for promoting bone development |
| AU2008231241A Ceased AU2008231241B2 (en) | 2007-02-22 | 2008-02-22 | Compositions and methods for enhancing neurologic development |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2008218176A Ceased AU2008218176B2 (en) | 2007-02-22 | 2008-02-22 | Compositions and methods for enhancing the development of growing animals |
| AU2008218187A Ceased AU2008218187C1 (en) | 2007-02-22 | 2008-02-22 | Compositions and methods for enhancing immune system of felines |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2008218193A Ceased AU2008218193B2 (en) | 2007-02-22 | 2008-02-22 | Compositions and methods for promoting bone development |
| AU2008231241A Ceased AU2008231241B2 (en) | 2007-02-22 | 2008-02-22 | Compositions and methods for enhancing neurologic development |
Country Status (12)
| Country | Link |
|---|---|
| US (6) | US20100143497A1 (enExample) |
| EP (5) | EP2124611B1 (enExample) |
| JP (5) | JP5474570B2 (enExample) |
| CN (6) | CN101686711A (enExample) |
| AU (5) | AU2008218176B2 (enExample) |
| BR (5) | BRPI0807373A2 (enExample) |
| CA (5) | CA2679065C (enExample) |
| DK (1) | DK2129237T3 (enExample) |
| ES (1) | ES2546284T3 (enExample) |
| RU (5) | RU2441394C2 (enExample) |
| WO (5) | WO2008103939A1 (enExample) |
| ZA (5) | ZA200906389B (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1937721B1 (en) * | 2005-08-25 | 2010-07-28 | Eli Lilly And Company | Anti-il-23 antibodies |
| AU2008218176B2 (en) * | 2007-02-22 | 2011-09-29 | Hill's Pet Nutrition, Inc. | Compositions and methods for enhancing the development of growing animals |
| CN102316865B (zh) * | 2008-12-12 | 2017-04-19 | 科耐特有限公司 | 用于改善正常的认知功能的l‑赖氨酸 |
| BR112012015959A2 (pt) | 2009-12-29 | 2019-09-24 | Hills Pet Nutrition Inc | composições incluindo gengibre para a melhora ou prevenção de condições inflamatórias |
| EP2568823B1 (en) * | 2010-05-12 | 2016-04-27 | Hill's Pet Nutrition, Inc. | Methods of diagnosis, control and prophylaxis of inflammation and mitigation of inflammatory conditions in felines |
| RU2551965C2 (ru) * | 2010-12-20 | 2015-06-10 | Хилл'С Пет Ньютришн, Инк. | Кормовые композиции для домашних животных, вызывающие чувство сытости |
| KR102100091B1 (ko) * | 2011-04-13 | 2020-04-14 | 아지노모토 가부시키가이샤 | 영양 조성물 |
| US8828426B2 (en) | 2011-06-07 | 2014-09-09 | Zx Pharma, Llc | Multiparticulate L-carnitine compositions and related methods |
| CN104039823A (zh) | 2011-12-19 | 2014-09-10 | 希尔氏宠物营养品公司 | 用于诊断和治疗伴侣动物的甲状腺机能亢进的组合物和方法 |
| CN103315187B (zh) * | 2013-07-17 | 2014-11-05 | 江苏桂龙生物技术有限公司 | 一种预防宠物骨骼性疾病的饲料 |
| CN104026401B (zh) * | 2014-06-10 | 2016-04-27 | 务川县绿之源农业技术推广中心 | 一种小型幼犬粮 |
| JP6896220B2 (ja) * | 2014-10-30 | 2021-06-30 | 不二製油株式会社 | 長鎖多価不飽和脂肪酸含有油脂およびそれを含有する食品 |
| GB201522300D0 (en) * | 2015-12-17 | 2016-02-03 | Mars Inc | Puppy growth food product |
| US11617737B2 (en) | 2016-12-15 | 2023-04-04 | Société des Produits Nestlé S.A. | Compositions and methods that modulate vitamin D and bone mineral content in a companion animal |
| CN109328020A (zh) | 2016-12-15 | 2019-02-12 | 雀巢产品技术援助有限公司 | 用于小型犬科动物的组合物和方法 |
| EP3630088B1 (en) * | 2017-05-29 | 2023-07-12 | Société des Produits Nestlé S.A. | Medium chain fatty acids for use in the prevention or treatment of valvular heart disease |
| WO2019155336A1 (en) * | 2018-02-08 | 2019-08-15 | Societe Des Produits Nestle S.A. | Mct-based nutrition blend for providing health benefits in companion animals |
| CN108244374A (zh) * | 2018-02-27 | 2018-07-06 | 佛山市雷米高动物营养保健科技有限公司 | 猫用营养粉剂及其制备方法 |
| CN113873896B (zh) * | 2019-02-01 | 2025-02-14 | 马斯公司 | 猫科动物食品组合物 |
| CN110537630A (zh) * | 2019-09-09 | 2019-12-06 | 天津农学院 | 1，2二硫戊环-3-戊酸的应用、幼犬鲜粮和延长幼犬鲜粮贮藏期的方法 |
| JP7626768B2 (ja) * | 2019-12-19 | 2025-02-04 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | 成長期の動物に健康上の効果をもたらすための組成物及び方法 |
| US20230165281A1 (en) * | 2021-11-29 | 2023-06-01 | Société des Produits Nestlé S.A. | Methods and compositions for providing a health benefit in an animal |
| WO2023150389A1 (en) * | 2022-02-07 | 2023-08-10 | Cornell University | Compositions and methods for increasing dha availability |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006072084A2 (en) * | 2004-12-30 | 2006-07-06 | Hill's Pet Nutrition, Inc. | Methods for enhancing the quality of life of a growing animal |
| WO2006074089A2 (en) * | 2004-12-30 | 2006-07-13 | Hill's Pet Nutrition, Inc. | Methods for enhancing the quality of life of a senior animal |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4267195A (en) * | 1976-09-10 | 1981-05-12 | University Of Texas | Dog food flavors |
| US4130651A (en) * | 1978-03-31 | 1978-12-19 | American Cyanamid Company | Butamisole injectable formulations having improved margin of safety in dogs |
| JPH0625057B2 (ja) * | 1987-12-14 | 1994-04-06 | 日本油脂株式会社 | 骨形成促進剤 |
| JPH04166039A (ja) * | 1990-10-26 | 1992-06-11 | Hirotoshi Yokura | ペットフード |
| US5690988A (en) * | 1996-02-02 | 1997-11-25 | Colgate Palmolive Company | Pet food composition of improved palatability and a method of enhancing the palatability of a food composition |
| US5851573A (en) | 1997-04-29 | 1998-12-22 | The Iams Company | Pet food composition for large breed puppies and method for promoting proper skeletal growth |
| US6156355A (en) * | 1998-11-02 | 2000-12-05 | Star-Kist Foods, Inc. | Breed-specific canine food formulations |
| GB2367489B (en) * | 2000-07-31 | 2005-02-09 | Mars Inc | Use of antioxidants |
| NZ527924A (en) * | 1999-01-29 | 2005-01-28 | Mars Uk Ltd | Antioxidant compositions and methods for companion animals |
| US6071544A (en) * | 1999-04-01 | 2000-06-06 | The Iams Company | Dietary compositions and method for promoting healthy weight loss cats |
| AU767764C (en) * | 1999-05-27 | 2005-08-18 | Mars, Incorporated | Process and product for enhancing immune response in companion animal using a combination of antioxidants |
| EG22407A (en) * | 2000-02-17 | 2003-01-29 | Iams Company | Method for improving bone modeling and chondrocyte functioning in growing canines |
| GB2367487A (en) | 2000-10-04 | 2002-04-10 | John Kennedy Mcmillan | Tooth cleaner |
| US6517877B2 (en) * | 2000-12-29 | 2003-02-11 | Martin Francis Gannon | Animal food product |
| US6582752B2 (en) * | 2001-11-02 | 2003-06-24 | Nestec, Ltd | Methods and compositions for a gender specific diet for puppies |
| CN1668214A (zh) * | 2002-07-12 | 2005-09-14 | 爱默思公司 | 饮食和与人类的交互作用对于狗的行为的协同影响 |
| WO2004008196A1 (ja) * | 2002-07-13 | 2004-01-22 | Autocloning Technology Ltd. | 偏光解析装置 |
| US20050271603A1 (en) | 2002-07-26 | 2005-12-08 | Stephanie Krammer | Compositions comprising lactoferrin |
| CA2518197A1 (en) * | 2003-03-07 | 2004-09-23 | Advanced Bionutrition Corporation | Feed formulation for terrestrial and aquatic animals |
| WO2004095940A1 (en) | 2003-04-25 | 2004-11-11 | The University Of Newcastle | Biomass containing animal feed |
| RU2349312C2 (ru) * | 2003-07-03 | 2009-03-20 | Хилл`С Пет Ньютришн, Инк. | Композиция и способ для ингибирования ухудшения умственных способностей у кошек |
| MXPA05013251A (es) * | 2003-07-07 | 2006-03-09 | Hills Pet Nutrition Inc | Composiciones para estado de oxigeno mejorado en animales de compania. |
| AU2004210599B2 (en) * | 2003-09-12 | 2009-09-24 | Mars, Incorporated | Food product for hairball treatment |
| US8921422B2 (en) | 2003-10-01 | 2014-12-30 | The Iams Company | Methods and kits for enhancing ability to learn in a puppy or kitten |
| US20050266051A1 (en) * | 2004-05-27 | 2005-12-01 | The Procter & Gamble Company | Pet food compositions and methods |
| JP5543688B2 (ja) * | 2004-08-30 | 2014-07-09 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | ゲノムベースのダイエットデザイン |
| CN1631207A (zh) | 2004-12-03 | 2005-06-29 | 王志文 | 能改善猫狗皮毛质量的不饱和脂肪酸饲料添加剂及饲料 |
| AU2006299665B2 (en) | 2005-09-30 | 2012-12-13 | Nestec S.A. | Methods and compositions for improving cognitive function |
| CA2635655C (en) * | 2006-01-10 | 2011-09-06 | Hill's Pet Nutrition, Inc. | Compositions and methods for promoting fat loss |
| CA2660291C (en) * | 2006-08-09 | 2011-11-22 | The Iams Company | Methods of improving bone health and muscle health |
| AU2008218176B2 (en) * | 2007-02-22 | 2011-09-29 | Hill's Pet Nutrition, Inc. | Compositions and methods for enhancing the development of growing animals |
-
2008
- 2008-02-22 AU AU2008218176A patent/AU2008218176B2/en not_active Ceased
- 2008-02-22 CA CA2679065A patent/CA2679065C/en not_active Expired - Fee Related
- 2008-02-22 CA CA2678938A patent/CA2678938C/en active Active
- 2008-02-22 CA CA2679008A patent/CA2679008C/en not_active Expired - Fee Related
- 2008-02-22 JP JP2009551040A patent/JP5474570B2/ja active Active
- 2008-02-22 BR BRPI0807373-2A patent/BRPI0807373A2/pt active Search and Examination
- 2008-02-22 JP JP2009551047A patent/JP5286287B2/ja not_active Expired - Fee Related
- 2008-02-22 BR BRPI0807691A patent/BRPI0807691A2/pt not_active Application Discontinuation
- 2008-02-22 WO PCT/US2008/054773 patent/WO2008103939A1/en not_active Ceased
- 2008-02-22 BR BRPI0807790-8A patent/BRPI0807790B1/pt not_active IP Right Cessation
- 2008-02-22 JP JP2009551049A patent/JP5474571B2/ja active Active
- 2008-02-22 WO PCT/US2008/054796 patent/WO2008103956A1/en not_active Ceased
- 2008-02-22 JP JP2009551043A patent/JP5286286B2/ja not_active Expired - Fee Related
- 2008-02-22 EP EP08730573.6A patent/EP2124611B1/en not_active Not-in-force
- 2008-02-22 AU AU2008218187A patent/AU2008218187C1/en not_active Ceased
- 2008-02-22 US US12/528,158 patent/US20100143497A1/en not_active Abandoned
- 2008-02-22 AU AU2008218195A patent/AU2008218195C1/en not_active Ceased
- 2008-02-22 US US12/528,164 patent/US9888709B2/en active Active
- 2008-02-22 EP EP08780443A patent/EP2124610A1/en not_active Ceased
- 2008-02-22 WO PCT/US2008/054786 patent/WO2008118586A1/en not_active Ceased
- 2008-02-22 US US12/528,137 patent/US20110059202A1/en not_active Abandoned
- 2008-02-22 RU RU2009135260/15A patent/RU2441394C2/ru not_active IP Right Cessation
- 2008-02-22 CN CN200880012994A patent/CN101686711A/zh active Pending
- 2008-02-22 BR BRPI0807789-4A2A patent/BRPI0807789A2/pt active Search and Examination
- 2008-02-22 EP EP08730572.8A patent/EP2129237B1/en not_active Not-in-force
- 2008-02-22 CN CN200880012951A patent/CN101662951A/zh active Pending
- 2008-02-22 ES ES08730572.8T patent/ES2546284T3/es active Active
- 2008-02-22 CN CN200880013110.4A patent/CN101686712B/zh not_active Expired - Fee Related
- 2008-02-22 RU RU2009135263/13A patent/RU2435435C2/ru not_active IP Right Cessation
- 2008-02-22 CA CA2679215A patent/CA2679215C/en not_active Expired - Fee Related
- 2008-02-22 CN CN2008800125423A patent/CN101662949B/zh not_active Expired - Fee Related
- 2008-02-22 US US12/528,153 patent/US20100104599A1/en not_active Abandoned
- 2008-02-22 RU RU2009135261/13A patent/RU2427278C2/ru not_active IP Right Cessation
- 2008-02-22 RU RU2009135245/13A patent/RU2412611C1/ru not_active IP Right Cessation
- 2008-02-22 DK DK08730572.8T patent/DK2129237T3/en active
- 2008-02-22 CN CN200880012712A patent/CN101662950A/zh active Pending
- 2008-02-22 AU AU2008218193A patent/AU2008218193B2/en not_active Ceased
- 2008-02-22 BR BRPI0807372-4A patent/BRPI0807372A2/pt not_active Application Discontinuation
- 2008-02-22 JP JP2009551045A patent/JP5285625B2/ja active Active
- 2008-02-22 US US12/528,362 patent/US20100137404A1/en not_active Abandoned
- 2008-02-22 AU AU2008231241A patent/AU2008231241B2/en not_active Ceased
- 2008-02-22 CN CN201410643425.4A patent/CN104472871A/zh active Pending
- 2008-02-22 WO PCT/US2008/054789 patent/WO2008103950A1/en not_active Ceased
- 2008-02-22 RU RU2009135231/13A patent/RU2436410C2/ru not_active IP Right Cessation
- 2008-02-22 EP EP08743532.7A patent/EP2124612B1/en not_active Not-in-force
- 2008-02-22 WO PCT/US2008/054800 patent/WO2008103958A1/en not_active Ceased
- 2008-02-22 CA CA2679682A patent/CA2679682C/en not_active Expired - Fee Related
- 2008-02-22 EP EP08730556.1A patent/EP2112889B1/en not_active Not-in-force
-
2009
- 2009-09-14 ZA ZA2009/06389A patent/ZA200906389B/en unknown
- 2009-09-14 ZA ZA2009/06388A patent/ZA200906388B/en unknown
- 2009-09-14 ZA ZA2009/06387A patent/ZA200906387B/en unknown
- 2009-09-14 ZA ZA2009/06390A patent/ZA200906390B/en unknown
- 2009-11-30 ZA ZA2009/08481A patent/ZA200908481B/en unknown
-
2010
- 2010-09-07 US US12/876,451 patent/US9848622B2/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006072084A2 (en) * | 2004-12-30 | 2006-07-06 | Hill's Pet Nutrition, Inc. | Methods for enhancing the quality of life of a growing animal |
| WO2006074089A2 (en) * | 2004-12-30 | 2006-07-13 | Hill's Pet Nutrition, Inc. | Methods for enhancing the quality of life of a senior animal |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2008218195B2 (en) | Compositions and methods for altering gene expression | |
| Dawood et al. | Dietary sodium butyrate ameliorated the blood stress biomarkers, heat shock proteins, and immune response of Nile tilapia (Oreochromis niloticus) exposed to heat stress | |
| CN101378771B (zh) | 用于延长寿命的营养系统和方法 | |
| EP3800271B1 (en) | Improving the level of hydration in a cat | |
| CN110121268A (zh) | 宠物食品组合物 | |
| EP2320752A1 (en) | Method for enhancing the quality of life of a senior animal | |
| Junghans et al. | Temporary consumption of a soy-based diet induces persisting alterations in protein metabolism and oxidative stress responsiveness in juvenile pigs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DA2 | Applications for amendment section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 18 JAN 2012. |
|
| DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 18 JAN 2012 |
|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |